NCT03918408View on ClinicalTrials.gov

Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Cross-Linking

PHASE1RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

September 1, 2019

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2030

Conditions
Keratoconus, UnstableBacterial KeratitisEctasia of Cornea
Interventions
COMBINATION_PRODUCT

PXL-330 Platinum device for crosslinking with Peschke ribofflavin solution

Riboflavin will be used to load the cornea, followed by UV-A crosslinking of the cornea

Trial Locations (1)

97401

RECRUITING

Pacific Clear Vision Institute, Eugene

All Listed Sponsors
lead

Pacific Clear Vision Institute

OTHER